A retrospective cohort study from UCLA reveals that the sustained use of medications for alcohol use disorder (MAUD) for three months or longer is associated with significantly improved 1-year and 3-year survival rates among patients with severe alcohol-related liver disease undergoing transplant evaluation.
CardiologyGastroenterology < class="penci-entry-title entry-title grid-title penci_grid_title">Extended use of AUD medications cut mortality risk in severe ALD